Bleeding after percutaneous coronary intervention in women and men matched for age, body mass index, and type of antithrombotic therapy

American Heart Journal

Volumn 166, Issue 3, 2013, Pages 534-540

  Ndrepepa, Gjin ^a   Schulz, Stefanie ^a   Neumann, Franz Josef ^b   Byrne, Robert A ^a   Hoppmann, Petra ^c   Cassese, Salvatore ^a   Ott, Ilka ^a   Fusaro, Massimiliano ^a   Ibrahim, Tareq ^c   Tada, Tomohisa ^a   Richardt, Gert ^d   Laugwitz, Karl Ludwig ^c,e   Schunkert, Heribert ^a,e   Kastrati, Adnan ^a,e  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d Herzzentrum der Segeberger Kliniken   (Germany)

^e DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; HEPARIN; HIRULOG;

AGED; ARTICLE; BLEEDING; BODY MASS; CORONARY STENT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC);

AGED; BODY MASS INDEX; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE HEMORRHAGE; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84883792886     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2013.07.006     Document Type: Article

References (37)

1. S.P. Marso, A.P. Amin, and J.A. House Association between use of bleeding avoidance strategies and risk of periprocedural bleeding among patients undergoing percutaneous coronary intervention JAMA 303 2010 2156 2164
2. G. Ndrepepa, P.B. Berger, and J. Mehilli Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point J Am Coll Cardiol 51 2008 690 697
3. M. Moscucci, K.A. Fox, and C.P. Cannon Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE) Eur Heart J 24 2003 1815 1823
4. D.S. Pinto, G.W. Stone, and C. Shi Economic evaluation of bivalirudin with or without glycoprotein IIb/IIIa inhibition versus heparin with routine glycoprotein IIb/IIIa inhibition for early invasive management of acute coronary syndromes J Am Coll Cardiol 52 2008 1758 1768
5. T.D. Kinnaird, E. Stabile, and G.S. Mintz Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions Am J Cardiol 92 2003 930 935
6. A.K. Chhatriwalla, A.P. Amin, and K.F. Kennedy Association between bleeding events and in-hospital mortality after percutaneous coronary intervention JAMA 309 2013 1022 1029
7. R. Mehran, S. Pocock, and E. Nikolsky Impact of bleeding on mortality after percutaneous coronary intervention results from a patient-level pooled analysis of the REPLACE-2 (randomized evaluation of PCI linking angiomax to reduced clinical events), ACUITY (acute catheterization and urgent intervention triage strategy), and HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trials JACC Cardiovasc Interv 4 2011 654 664
8. J.S. Berger, T.A. Sanborn, and W. Sherman Influence of sex on in-hospital outcomes and long-term survival after contemporary percutaneous coronary intervention Am Heart J 151 2006 1026 1031
9. M. Chacko, A.M. Lincoff, and K.E. Wolski Ischemic and bleeding outcomes in women treated with bivalirudin during percutaneous coronary intervention: a subgroup analysis of the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE)-2 trial Am Heart J 151 2006 1032 e1-7
10. S.L. Daugherty, L.E. Thompson, and S. Kim Patterns of use and comparative effectiveness of bleeding avoidance strategies in men and women following percutaneous coronary interventions: an observational study from the National Cardiovascular Data Registry® J Am Coll Cardiol 61 2013 2070 2078
11. B. Ahmed, W.D. Piper, and D. Malenka Significantly improved vascular complications among women undergoing percutaneous coronary intervention: a report from the Northern New England Percutaneous Coronary Intervention Registry Circ Cardiovasc Interv 2 2009 423 429
12. M.R. Bell, D.E. Grill, and K.N. Garratt Long-term outcome of women compared with men after successful coronary angioplasty Circulation 91 1995 2876 2881
13. E.D. Peterson, A.J. Lansky, and J. Kramer National Cardiovascular Network Clinical I. Effect of gender on the outcomes of contemporary percutaneous coronary intervention Am J Cardiol 88 2001 359 364
14. V.S. Srinivas, S. Garg, and A. Negassa Persistent sex difference in hospital outcome following percutaneous coronary intervention: results from the New York State reporting system J Invasive Cardiol 19 2007 265 268
15. B. Ahmed, and H.L. Dauerman Women, bleeding, and coronary intervention Circulation 127 2013 641 649
16. N. Cox, F.S. Resnic, and J.J. Popma Comparison of the risk of vascular complications associated with femoral and radial access coronary catheterization procedures in obese versus nonobese patients Am J Cardiol 94 2004 1174 1177
17. R. Glaser, H.C. Herrmann, and S.A. Murphy Benefit of an early invasive management strategy in women with acute coronary syndromes JAMA 288 2002 3124 3129
18. F. Feit, M.D. Voeltz, and M.J. Attubato Predictors and impact of major hemorrhage on mortality following percutaneous coronary intervention from the REPLACE-2 Trial Am J Cardiol 100 2007 1364 1369
19. P.G. Steg, K. Huber, and F. Andreotti Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology Eur Heart J 32 2011 1854 1864
20. C. Delhaye, K. Wakabayashi, and G. Maluenda Body mass index and bleeding complications after percutaneous coronary intervention: does bivalirudin make a difference? Am Heart J 159 2010 1139 1146
21. A. Kastrati, J. Mehilli, and H. Schuhlen A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel N Engl J Med 350 2004 232 238
22. J. Mehilli, A. Kastrati, and H. Schuhlen Randomized clinical trial of abciximab in diabetic patients undergoing elective percutaneous coronary interventions after treatment with a high loading dose of clopidogrel Circulation 110 2004 3627 3635
23. J. Hausleiter, A. Kastrati, and J. Mehilli A randomized trial comparing phosphorylcholine-coated stenting with balloon angioplasty as well as abciximab with placebo for restenosis reduction in small coronary arteries J Intern Med 256 2004 388 397
24. A. Kastrati, J. Mehilli, and F.J. Neumann Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial JAMA 295 2006 1531 1538
25. A. Kastrati, F.J. Neumann, and J. Mehilli Bivalirudin versus unfractionated heparin during percutaneous coronary intervention N Engl J Med 359 2008 688 696
26. S. Schulz, J. Mehilli, and F.J. Neumann ISAR-REACT 3A: a study of reduced dose of unfractionated heparin in biomarker negative patients undergoing percutaneous coronary intervention Eur Heart J 31 2010 2482 2491
27. A. Kastrati, F.J. Neumann, and S. Schulz Abciximab and heparin versus bivalirudin for non-ST-elevation myocardial infarction N Engl J Med 365 21 2011 1980 1989
28. D.W. Cockcroft, and M.H. Gault Prediction of creatinine clearance from serum creatinine Nephron 16 1976 31 41
29. R. Mehran, S.V. Rao, and D.L. Bhatt Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium Circulation 123 2011 2736 2747
30. G. Ndrepepa, T. Schuster, and M. Hadamitzky Validation of the Bleeding Academic Research Consortium definition of bleeding in patients with coronary artery disease undergoing percutaneous coronary intervention Circulation 125 11 2012 1424 1431
31. P.M. Grambsch, and T.M. Therneau Proportional hazards tests and diagnostics based on weighted residuals Biometrika 81 1994 515 526
32. K.P. Alexander, A.Y. Chen, and L.K. Newby Sex differences in major bleeding with glycoprotein IIb/IIIa inhibitors: results from the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) initiative Circulation 114 2006 1380 1387
33. G. Wannamethee, and A.G. Shaper Body weight and mortality in middle aged British men: impact of smoking BMJ 299 1989 1497 1502
34. E. Argulian, A.D. Patel, and J.L. Abramson Gender differences in short-term cardiovascular outcomes after percutaneous coronary interventions Am J Cardiol 98 2006 48 53
35. T. Sandgren, B. Sonesson, and R. Ahlgren The diameter of the common femoral artery in healthy human: influence of sex, age, and body size J Vasc Surg 29 1999 503 510
36. G. Schnyder, N. Sawhney, and B. Whisenant Common femoral artery anatomy is influenced by demographics and comorbidity: implications for cardiac and peripheral invasive studies Catheter Cardiovasc Interv 53 2001 289 295
37. F.W. Verheugt, S.R. Steinhubl, and M. Hamon Incidence, prognostic impact, and influence of antithrombotic therapy on access and nonaccess site bleeding in percutaneous coronary intervention JACC Cardiovasc Interv 4 2011 191 197